Search results
Helpful Tips to Secure Your Child’s Health and Future
Mercola· 18 hours agoIn this interview, Dr. Lawrence (Larry) Palevsky, a practicing pediatrician, discusses the impact that mainstream propaganda narratives have on our children, and why it's so important to get ...
‘Essential worker’ claiming vaccine side effects now seeks workers’ comp
Iowa Capital Dispatch via Yahoo News· 5 days agoA Cedar Rapids city employee is seeking workers’ compensation benefits for injuries he attributes to...
Man behind China’s first approved Covid-19 shot loses seat in legislature
South China Morning Post· 7 days agoThe NPC statement, which followed a four-day meeting of its standing committee, suggests Yang is...
Moderna Swings to 1Q Loss, But Sees Data on New Vaccine Later in '24
Market Watch· 3 days agoModerna swung to a hefty first-quarter loss but the maker of Covid 19 vaccines forecast some seasonal strength in sales in the second ...
COVID-19 hospitalizations hit record low, the CDC says
ABC News· 5 days agoWeekly COVID-19 hospitalizations have hit their lowest level ever reported since the pandemic began,...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 4 days agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Vaccine Against Urinary Tract Infections in Development
Medscape· 5 days agoA randomized study published in 2022 showed the vaccine's efficacy in preventing urinary tract...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 3 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Louisiana House splits on vaccine ‘discrimination’ proposals
KTBS Shreveport· 4 days agoDr. Obi Nnedu, Infectious Disease specialist, receives his COVID-19 vaccine injection at Ochsner Medical Center in Jefferson on Monday ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 4 days agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts ...